Task: Answer the MCQ question.
Question: Which drug exhibits a 2.726% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCCCN(CC)C(=O)CN(C)S(=O)(=O)c1cccc2nsnc12
[b] Cc1cc(Br)ccc1OCC(=O)N(Cc1nc(-c2ccccc2)no1)C(C)C
Answer: a. CCCCN(CC)C(=O)CN(C)S(=O)(=O)c1cccc2nsnc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)C(=O)CN(C)S(=O)(=O)c1cccc2nsnc12
CCCCN(CC)C(=O)CN(C)S(=O)(=O)c1cccc2nsnc12
2-[2,1,3-benzothiadiazol-4-ylsulfonyl(methyl)amino]-N-butyl-N-ethylacetamide